OBSOLETE: Hemolytic anemia due to glyceraldehyde-3-phosphate dehydrogenase deficiency

Hemolytic anemia due to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) deficiency is an extremely rare inherited blood disorder. In this condition, red blood cells lack sufficient amounts of the enzyme GAPDH, which plays an important role in glycolysis — the process by which cells break down sugar (glucose) to produce energy. When red blood cells cannot produce enough energy, they become fragile and break apart prematurely, a process called hemolysis. This leads to hemolytic anemia, meaning the body destroys red blood cells faster than it can replace them. It is important to note that this condition is classified as 'OBSOLETE' in the Orphanet database, meaning the designation has been retired or reclassified. This may be because the condition was never conclusively confirmed as a distinct clinical entity, or because it has been reclassified under a broader category of red blood cell enzyme deficiencies. Very few cases have ever been reported in the medical literature, and the existence of this as a standalone disorder remains uncertain. Symptoms, when described, would be expected to include fatigue, pale skin, yellowing of the skin and eyes (jaundice), dark urine, and an enlarged spleen. Treatment would generally be supportive, focusing on managing anemia through blood transfusions if needed and monitoring for complications. Because this condition is so poorly characterized, patients who suspect they have a red blood cell enzyme deficiency should work closely with a hematologist and clinical geneticist to obtain an accurate diagnosis.

Bring these to your next appointment

• Q1.Has my diagnosis been confirmed with enzyme activity testing, and could another red blood cell enzyme deficiency be the cause?,How severe is the anemia, and will I or my child need regular blood transfusions?,Should we pursue genetic testing to confirm the diagnosis?,What signs of a hemolytic crisis should I watch for, and when should I go to the emergency room?,Is folic acid supplementation recommended in my case?,Should splenectomy be considered, and what are the risks and benefits?,Are there any clinical trials or research studies I should know about?

Common questions about OBSOLETE: Hemolytic anemia due to glyceraldehyde-3-phosphate dehydrogenase deficiency